Drug intelligence / Profile preview

potassium bicarbonate

Development stage: Approved
Modality: Small Molecules
Administration: Oral

Overview

Potassium bicarbonate is a small molecule mineral supplement and antacid used primarily to treat or prevent hypokalemia (low blood potassium levels)[1][2][3][5]. It acts as an electrolyte replenisher by providing bioavailable potassium ions and as an antacid by neutralizing gastric acid[1]. The compound is also used in some drug formulations as an excipient. Its mechanism of action involves increasing serum potassium concentrations and buffering excess acid in the body. Potassium bicarbonate is considered generally recognized as safe (GRAS) for use in over-the-counter antacids[1]. It is supplied mainly as effervescent oral tablets.

Brand names: Effer-KKlor-Con/EFK-EffervescentK+Care ETEffervescent PotassiumK-vescentK-LyteK-Lyte DSK-Prime
Other names: potassium bicarbonate

Beyond the preview

Go deeper on potassium bicarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium bicarbonate.

Explore the full profile